Skip to main content

Tissue Ablation by Irreversible Electroporation

  • Living reference work entry
  • First Online:
Handbook of Electroporation

Abstract

The phenomenon of electroporation can be traced back to the eighteenth century when red spots on skin (Lichtenberg figures) were observed in the areas where electric fields were applied. Once the cause of this occurrence was understood and controlled, induction of electric fields was achieved; the use of pulsed electric fields was adopted in the areas of food and water sterilization to kill microbial organisms. Applications in biomedicine soon followed where electric fields began to play a role in the transport of and into biological material employing a technique known as reversible electroporation in which temporary cell membrane destabilization is achieved followed by complete recovery of membrane integrity. Irreversible electroporation (IRE) induces cell death presumably through a loss of homeostasis by using an energy regime substantially higher than that of reversible electroporation. When pulse parameters are carefully designed, IRE can be used to ablate large volumes of tissue in such a manner that it does not induce significant traditional thermal damage. This application of IRE for the treatment of disease has been widely investigated through in vitro studies, in vivo animal studies, and treating human patients through clinical trials. Its nonthermal mechanism to induce cell death makes it an attractive modality to safely treat unresectable tumors. When careful treatment planning is performed to account for tumor morphology, tissue heterogeneity, and parameters for pulse delivery, it has been shown to successfully treat cancerous tumors safely. Clinical use of IRE includes the treatment of liver, lung, pancreas, and prostate cancer among others. IRE has found tremendous promise for the treatment of pancreatic and prostate tumors. Further research and optimization of this technique point to an accelerated adoption for its clinical use to treat various types of cancer and other debilitating conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  • Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, Davalos RV, … Mir LM (2007) Tumor ablation with irreversible electroporation. PLoS One 2(11):e1135. doi:10.1371/journal.pone.0001135

    Google Scholar 

  • Arena CB, Sano MB, Rossmeisl JH, Caldwell JL, Garcia PA, Rylander MN, Davalos RV (2011) High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction. Biomed Eng Online 10:102. doi:10.1186/1475-925X-10-102

    Article  Google Scholar 

  • Bhonsle SP, Arena CB, Sweeney DC, Davalos RV (2015) Mitigation of impedance changes due to electroporation therapy using bursts of high-frequency bipolar pulses. Biomed Eng Online 14(Suppl 3):S3. doi:10.1186/1475-925X-14-S3-S3

    Article  Google Scholar 

  • Cannon R, Ellis S, Hayes D, Narayanan G, Martin RCG 2nd (2013) Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 107(5):544–549. 10.1002/jso.23280

    Google Scholar 

  • Davalos RV, Mir IL, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33(2):223–231. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15771276

  • Garcia PA, Davalos RV, Miklavcic D (2014) A numerical investigation of the electric and thermal cell kill distributions in electroporation-based therapies in tissue. PLoS One 9(8). doi:10.1371/journal.pone.0103083

    Google Scholar 

  • Garcia PA, Pancotto T, Rossmeisl JH, Henao-Guerrero N, Gustafson NR, Daniel, GB, … Davalos RV (2011) Non-thermal irreversible electroporation (N-TIRE) and adjuvant fractionated radiotherapeutic multimodal therapy for intracranial malignant glioma in a canine patient. Technol Cancer Res Treat 10(1):73–83.

    Google Scholar 

  • Golberg A, Rubinsky B (2010) A statistical model for multidimensional irreversible electroporation cell death in tissue. Biomed Eng Online 9(1):13. doi:10.1186/1475-925X-9-13

    Article  Google Scholar 

  • Hofmann F, Ohnimus H, Scheller C, Strupp W, Zimmermann U, Jassoy C (1999) Electric field pulses can induce apoptosis. J Membr Biol 169(2):103–109. doi:10.1007/s002329900522

    Article  Google Scholar 

  • Ivorra A, Rubinsky B (2007) In vivo electrical impedance measurements during and after electroporation of rat liver. Bioelectrochemistry 70(2):287–295. doi:10.1016/j.bioelechem.2006.10.005

    Article  Google Scholar 

  • Kos B, Voigt P, Miklavcic D, Moche M (2015) Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE). Radiol Oncol 49(3):234–241. doi:10.1515/raon-2015-0031

    Article  Google Scholar 

  • Lee RC, Gaylor DC, Bhatt D, Israel DA (1988) Role of cell membrane rupture in the pathogenesis of electrical trauma. J Surg Res 44(6):709–719. doi:10.1016/0022-4804(88)90105-9

    Article  Google Scholar 

  • Lee EW, Thai S, Kee ST (2010) Irreversible electroporation: a novel image-guided cancer therapy. Gut Liver. doi:10.5009/gnl.2010.4.S1.S99

    Google Scholar 

  • Martin RCG, McFarland K, Ellis S, Velanovich V (2013) Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol 20(Suppl 3):S443–S449. doi:10.1245/s10434-012-2736-1

    Article  Google Scholar 

  • Martin RCG, Kwon D, Chalikonda S, Sellers M, Kotz E, Scoggins C, … Watkins K (2015) Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation safety and efficacy. Ann Surg 262(3):486–494. doi:10.1097/SLA.0000000000001441

    Google Scholar 

  • Miklavcic D, Semrov D, Mekid H, Mir LM (2000) A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 1523(1):73–83. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11099860

  • Narayanan G, Doshi MH (2016) Irreversible electroporation (IRE) in renal tumors. Curr Urol Rep. doi:10.1007/s11934-015-0571-1

    Google Scholar 

  • Narayanan G, Hosein PJ, Arora G, Barbery KJ, Froud T, Livingstone AS, … Yrizarry J (2012) Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol 23(12):1613–1621. doi:10.1016/j.jvir.2012.09.012

    Google Scholar 

  • Neal RE 2nd, Davalos RV (2009) The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems. Ann Biomed Eng 37(12):2615–2625. doi:10.1007/s10439-009-9796-9

    Article  Google Scholar 

  • Neal RE 2nd, Rossmeisl JH Jr, Garcia PA, Lanz OI, Henao-Guerrero N, Davalos RV (2011) Successful treatment of a large soft tissue sarcoma with irreversible electroporation. J Clin Oncol 29(13):e372–e377. doi:10.1200/JCO.2010.33.0902

    Article  Google Scholar 

  • Onik G, Rubinsky B (2010) Irreversible electroporation: first patient experience focal therapy of prostate cancer. In: Rubinsky B (ed) Irreversible electroporation. Springer, Heidelberg. doi:10.1007/978-3-642-05420-4_10

    Google Scholar 

  • Onik G, Mikus P, Rubinsky B (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 6(4):295–300. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17668936

  • Pech M, Janitzky A, Wendler JJ, Strang C, Blaschke S, Dudeck O, … Liehr UB (2011). Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol 34(1):132–138. doi:10.1007/s00270-010-9964-1

    Google Scholar 

  • Piñero J, López-Baena M, Ortiz T, Cortés F (1997) Apoptotic and necrotic cell death are both induced by electroporation in HL60 human promyeloid leukaemia cells. Apoptosis 2(3):330–336. doi:10.1023/A:1026497306006

    Article  Google Scholar 

  • Scheffer HJ, Melenhorst MC, Vogel JA, van Tilborg AA, Nielsen K, Kazemier G, Meijerink MR (2015a) Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: a case report. Cardiovasc Intervent Radiol 38(3):760–765. doi:10.1007/s00270-014-0950-x

    Article  Google Scholar 

  • Scheffer HJ, Vroomen LGPH, Nielsen K, van Tilborg AAJM, Comans EFI, van Kuijk C, … Meijerink MR (2015b). Colorectal liver metastatic disease: efficacy of irreversible electroporation-a single-arm phase II clinical trial (COLDFIRE-2 trial). BMC Cancer 15:772. doi:10.1186/s12885-015-1736-5

    Google Scholar 

  • Thomson KR, Cheung W, Ellis SJ, Federman D, Kavnoudias H, Loader-Oliver D, … Haydon A (2011). Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 22(5):611–621. doi:10.1016/j.jvir.2010.12.014

    Google Scholar 

  • Trimmer CK, Khosla A, Morgan M, Stephenson SL, Ozayar A, Cadeddu JA (2015) Minimally invasive percutaneous treatment of small renal tumors with irreversible electroporation: a single-center experience. J Vasc Interv Radiol 26(10):1466–1471. doi:10.1016/j.jvir.2015.06.028

    Article  Google Scholar 

  • Usman M, Moore W, Talati R, Watkins K, Bilfinger TV (2012) Irreversible electroporation of lung neoplasm: a case series. Med Sci Monit 18(6):CS43–CS47. https://doi.org/10.12659/MSM.882888

    Article  Google Scholar 

  • Wendler JJ, Porsch M, Nitschke S, Kollermann J, Siedentopf S, Pech M, … Liehr UB (2015) A prospective phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). Contemp Clin Trials 43:10–19. doi:10.1016/j.cct.2015.05.002

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rafael V. Davalos .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Rolong, A., Rubinsky, B., Davalos, R.V. (2017). Tissue Ablation by Irreversible Electroporation. In: Miklavcic, D. (eds) Handbook of Electroporation. Springer, Cham. https://doi.org/10.1007/978-3-319-26779-1_166-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26779-1_166-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26779-1

  • Online ISBN: 978-3-319-26779-1

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics